Home › Pancreatic Ductal Carcinoma
Pancreatic Ductal Carcinoma clinical trials recruiting in the U.S.
5 studies for Pancreatic Ductal Carcinoma are recruiting participants at sites across the United States.
Cities with the most studies
- Nashville, TN4 studies
- Boston, MA4 studies
- Orange, CA3 studies
- San Antonio, TX3 studies
- Cincinnati, OH3 studies
- Scottsdale, AZ3 studies
- New York City, NY3 studies
- Arlington, VA3 studies
- Tampa, FL3 studies
- Houston, TX3 studies
By state
- Arizona3 studies
- California5 studies
- Florida4 studies
- Massachusetts4 studies
- Michigan3 studies
- New York4 studies
- Ohio3 studies
- Pennsylvania3 studies
- Tennessee4 studies
- Texas4 studies
- Virginia3 studies
Recently updated studies
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07259317Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06850623From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.